2025 Adverse Effect ICD-10-CM Codes - Page 3
The 2025 Adverse Effect ICD-10-CM Codes list includes 2,107 codes for documenting harmful or unintended reactions to drugs or substances taken as prescribed or directed. These are not poisonings but side effects from proper use of medications. Coders must identify the specific drug involved and ensure that documentation supports an adverse effect rather than misuse. Reporting adverse effects correctly prevents claim denials and ensures accurate clinical data collection. No external cause code is required.
- Poisoning by, adverse effect of and underdosing of agents pr
- Poisoning by, adverse effect of and underdosing of agents pr
- Poisoning by, adverse effect of and underdosing of agents pr
- Poisoning by, adverse effect of and underdosing of diuretics
- Poisoning by, adverse effect of and underdosing of primarily
- Poisoning by, adverse effect of and underdosing of topical a
T48.0X1S - Poisoning by oxytocic drugs, accidental (unintentional), sequela Billable
T48.0X2S - Poisoning by oxytocic drugs, intentional self-harm, sequela Billable
T48.0X3S - Poisoning by oxytocic drugs, assault, sequela Billable
T48.0X4S - Poisoning by oxytocic drugs, undetermined, sequela Billable
T48.0X5 - Adverse effect of oxytocic drugs Non-Billable
T48.0X5A - Adverse effect of oxytocic drugs, initial encounter Billable
T48.0X5D - Adverse effect of oxytocic drugs, subsequent encounter Billable
T48.0X5S - Adverse effect of oxytocic drugs, sequela Billable
T48.0X6S - Underdosing of oxytocic drugs, sequela Billable
T48.1X1S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), sequela Billable
T48.1X2S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela Billable
T48.1X3S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, sequela Billable
T48.1X4S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, sequela Billable
T48.1X5 - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents] Non-Billable
T48.1X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter Billable
T48.1X5D - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter Billable
T48.1X5S - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela Billable
T48.1X6S - Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela Billable
T48.201S - Poisoning by unspecified drugs acting on muscles, accidental (unintentional), sequela Billable
T48.202S - Poisoning by unspecified drugs acting on muscles, intentional self-harm, sequela Billable
T48.203S - Poisoning by unspecified drugs acting on muscles, assault, sequela Billable
T48.204S - Poisoning by unspecified drugs acting on muscles, undetermined, sequela Billable
T48.205 - Adverse effect of unspecified drugs acting on muscles Non-Billable
T48.205A - Adverse effect of unspecified drugs acting on muscles, initial encounter Billable
T48.205D - Adverse effect of unspecified drugs acting on muscles, subsequent encounter Billable
T48.205S - Adverse effect of unspecified drugs acting on muscles, sequela Billable
T48.206S - Underdosing of unspecified drugs acting on muscles, sequela Billable
T48.291S - Poisoning by other drugs acting on muscles, accidental (unintentional), sequela Billable
T48.292S - Poisoning by other drugs acting on muscles, intentional self-harm, sequela Billable
T48.293S - Poisoning by other drugs acting on muscles, assault, sequela Billable
T48.294S - Poisoning by other drugs acting on muscles, undetermined, sequela Billable
T48.295 - Adverse effect of other drugs acting on muscles Non-Billable
T48.295A - Adverse effect of other drugs acting on muscles, initial encounter Billable
T48.295D - Adverse effect of other drugs acting on muscles, subsequent encounter Billable
T48.295S - Adverse effect of other drugs acting on muscles, sequela Billable
T48.296S - Underdosing of other drugs acting on muscles, sequela Billable
T48.3X1S - Poisoning by antitussives, accidental (unintentional), sequela Billable
T48.3X2S - Poisoning by antitussives, intentional self-harm, sequela Billable
T48.3X3S - Poisoning by antitussives, assault, sequela Billable
T48.3X4S - Poisoning by antitussives, undetermined, sequela Billable
T48.3X5 - Adverse effect of antitussives Non-Billable
T48.3X5A - Adverse effect of antitussives, initial encounter Billable
T48.3X5D - Adverse effect of antitussives, subsequent encounter Billable
T48.3X5S - Adverse effect of antitussives, sequela Billable
T48.3X6S - Underdosing of antitussives, sequela Billable
T48.4X1S - Poisoning by expectorants, accidental (unintentional), sequela Billable
T48.4X2S - Poisoning by expectorants, intentional self-harm, sequela Billable
T48.4X3S - Poisoning by expectorants, assault, sequela Billable
T48.4X4S - Poisoning by expectorants, undetermined, sequela Billable
T48.4X5 - Adverse effect of expectorants Non-Billable
T48.4X5A - Adverse effect of expectorants, initial encounter Billable
T48.4X5D - Adverse effect of expectorants, subsequent encounter Billable
T48.4X5S - Adverse effect of expectorants, sequela Billable
T48.4X6S - Underdosing of expectorants, sequela Billable
T48.5X1S - Poisoning by other anti-common-cold drugs, accidental (unintentional), sequela Billable
T48.5X2S - Poisoning by other anti-common-cold drugs, intentional self-harm, sequela Billable
T48.5X3S - Poisoning by other anti-common-cold drugs, assault, sequela Billable
T48.5X4S - Poisoning by other anti-common-cold drugs, undetermined, sequela Billable
T48.5X5 - Adverse effect of other anti-common-cold drugs Non-Billable
T48.5X5A - Adverse effect of other anti-common-cold drugs, initial encounter Billable
T48.5X5D - Adverse effect of other anti-common-cold drugs, subsequent encounter Billable
T48.5X5S - Adverse effect of other anti-common-cold drugs, sequela Billable
T48.5X6S - Underdosing of other anti-common-cold drugs, sequela Billable
T48.6X1S - Poisoning by antiasthmatics, accidental (unintentional), sequela Billable
T48.6X2S - Poisoning by antiasthmatics, intentional self-harm, sequela Billable
T48.6X3S - Poisoning by antiasthmatics, assault, sequela Billable
T48.6X4S - Poisoning by antiasthmatics, undetermined, sequela Billable
T48.6X5 - Adverse effect of antiasthmatics Non-Billable
T48.6X5A - Adverse effect of antiasthmatics, initial encounter Billable
T48.6X5D - Adverse effect of antiasthmatics, subsequent encounter Billable
T48.6X5S - Adverse effect of antiasthmatics, sequela Billable
T48.6X6S - Underdosing of antiasthmatics, sequela Billable
T48.901S - Poisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), sequela Billable
T48.902S - Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, sequela Billable
T48.903S - Poisoning by unspecified agents primarily acting on the respiratory system, assault, sequela Billable
T48.904S - Poisoning by unspecified agents primarily acting on the respiratory system, undetermined, sequela Billable
T48.905 - Adverse effect of unspecified agents primarily acting on the respiratory system Non-Billable
T48.905A - Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter Billable
T48.905D - Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter Billable
T48.905S - Adverse effect of unspecified agents primarily acting on the respiratory system, sequela Billable
T48.906S - Underdosing of unspecified agents primarily acting on the respiratory system, sequela Billable
T48.991S - Poisoning by other agents primarily acting on the respiratory system, accidental (unintentional), sequela Billable
T48.992S - Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, sequela Billable
T48.993S - Poisoning by other agents primarily acting on the respiratory system, assault, sequela Billable
T48.994S - Poisoning by other agents primarily acting on the respiratory system, undetermined, sequela Billable
T48.995A - Adverse effect of other agents primarily acting on the respiratory system, initial encounter Billable
T48.995D - Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter Billable
T48.995S - Adverse effect of other agents primarily acting on the respiratory system, sequela Billable
T48.996S - Underdosing of other agents primarily acting on the respiratory system, sequela Billable
T46.0X1S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela Billable
T46.0X2S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela Billable
T46.0X3S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela Billable
T46.0X4S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela Billable
T46.0X5 - Adverse effect of cardiac-stimulant glycosides and drugs of similar action Non-Billable
T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter Billable
T46.0X5D - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter Billable
T46.0X5S - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela Billable
T46.0X6S - Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela Billable
T46.1X1S - Poisoning by calcium-channel blockers, accidental (unintentional), sequela Billable
T46.1X2S - Poisoning by calcium-channel blockers, intentional self-harm, sequela Billable
T46.1X3S - Poisoning by calcium-channel blockers, assault, sequela Billable
T46.1X4S - Poisoning by calcium-channel blockers, undetermined, sequela Billable
T46.1X5 - Adverse effect of calcium-channel blockers Non-Billable
T46.1X5A - Adverse effect of calcium-channel blockers, initial encounter Billable
T46.1X5D - Adverse effect of calcium-channel blockers, subsequent encounter Billable
T46.1X5S - Adverse effect of calcium-channel blockers, sequela Billable
T46.1X6S - Underdosing of calcium-channel blockers, sequela Billable
T46.2X1S - Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela Billable
T46.2X2S - Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela Billable
T46.2X3S - Poisoning by other antidysrhythmic drugs, assault, sequela Billable
T46.2X4S - Poisoning by other antidysrhythmic drugs, undetermined, sequela Billable
T46.2X5 - Adverse effect of other antidysrhythmic drugs Non-Billable
T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter Billable
T46.2X5D - Adverse effect of other antidysrhythmic drugs, subsequent encounter Billable
T46.2X5S - Adverse effect of other antidysrhythmic drugs, sequela Billable
T46.2X6S - Underdosing of other antidysrhythmic drugs, sequela Billable
T46.3X1S - Poisoning by coronary vasodilators, accidental (unintentional), sequela Billable
T46.3X2S - Poisoning by coronary vasodilators, intentional self-harm, sequela Billable
T46.3X3S - Poisoning by coronary vasodilators, assault, sequela Billable
T46.3X4S - Poisoning by coronary vasodilators, undetermined, sequela Billable
T46.3X5 - Adverse effect of coronary vasodilators Non-Billable
T46.3X5A - Adverse effect of coronary vasodilators, initial encounter Billable
T46.3X5D - Adverse effect of coronary vasodilators, subsequent encounter Billable
T46.3X5S - Adverse effect of coronary vasodilators, sequela Billable
T46.3X6S - Underdosing of coronary vasodilators, sequela Billable
T46.4X1S - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela Billable
T46.4X2S - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela Billable
T46.4X3S - Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela Billable
T46.4X4S - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela Billable
T46.4X5 - Adverse effect of angiotensin-converting-enzyme inhibitors Non-Billable
T46.4X5A - Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter Billable
T46.4X5D - Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter Billable
T46.4X5S - Adverse effect of angiotensin-converting-enzyme inhibitors, sequela Billable
T46.4X6S - Underdosing of angiotensin-converting-enzyme inhibitors, sequela Billable
T46.5X1S - Poisoning by other antihypertensive drugs, accidental (unintentional), sequela Billable
T46.5X2S - Poisoning by other antihypertensive drugs, intentional self-harm, sequela Billable
T46.5X3S - Poisoning by other antihypertensive drugs, assault, sequela Billable
T46.5X4S - Poisoning by other antihypertensive drugs, undetermined, sequela Billable
T46.5X5 - Adverse effect of other antihypertensive drugs Non-Billable
T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter Billable
T46.5X5D - Adverse effect of other antihypertensive drugs, subsequent encounter Billable
T46.5X5S - Adverse effect of other antihypertensive drugs, sequela Billable
T46.5X6S - Underdosing of other antihypertensive drugs, sequela Billable
T46.6X1S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela Billable
T46.6X2S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela Billable
T46.6X3S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela Billable
T46.6X4S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela Billable
T46.6X5 - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs Non-Billable
T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter Billable
T46.6X5D - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter Billable
T46.6X5S - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable
T46.6X6S - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable
T46.7X1S - Poisoning by peripheral vasodilators, accidental (unintentional), sequela Billable
T46.7X2S - Poisoning by peripheral vasodilators, intentional self-harm, sequela Billable
T46.7X3S - Poisoning by peripheral vasodilators, assault, sequela Billable
T46.7X4S - Poisoning by peripheral vasodilators, undetermined, sequela Billable
T46.7X5 - Adverse effect of peripheral vasodilators Non-Billable
T46.7X5A - Adverse effect of peripheral vasodilators, initial encounter Billable
T46.7X5D - Adverse effect of peripheral vasodilators, subsequent encounter Billable
T46.7X5S - Adverse effect of peripheral vasodilators, sequela Billable
T46.7X6S - Underdosing of peripheral vasodilators, sequela Billable
T46.8X1S - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela Billable
T46.8X2S - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela Billable
T46.8X3S - Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela Billable
T46.8X4S - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela Billable
T46.8X5 - Adverse effect of antivaricose drugs, including sclerosing agents Non-Billable
T46.8X5A - Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter Billable
T46.8X5D - Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter Billable
T46.8X5S - Adverse effect of antivaricose drugs, including sclerosing agents, sequela Billable
T46.8X6S - Underdosing of antivaricose drugs, including sclerosing agents, sequela Billable
T46.901S - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable
T46.902S - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable
T46.903S - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela Billable
T46.904S - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela Billable
T46.905 - Adverse effect of unspecified agents primarily affecting the cardiovascular system Non-Billable
T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter Billable
T46.905D - Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter Billable
T46.905S - Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela Billable
T46.906S - Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela Billable
T46.991S - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable
T46.992S - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable
T46.993S - Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela Billable
T46.994S - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela Billable
T46.995 - Adverse effect of other agents primarily affecting the cardiovascular system Non-Billable
T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter Billable
T46.995D - Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter Billable
T46.995S - Adverse effect of other agents primarily affecting the cardiovascular system, sequela Billable
T46.996S - Underdosing of other agents primarily affecting the cardiovascular system, sequela Billable
T47.0X1S - Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela Billable
T47.0X2S - Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela Billable
T47.0X3S - Poisoning by histamine H2-receptor blockers, assault, sequela Billable
T47.0X4S - Poisoning by histamine H2-receptor blockers, undetermined, sequela Billable
T47.0X5 - Adverse effect of histamine H2-receptor blockers Non-Billable
T47.0X5A - Adverse effect of histamine H2-receptor blockers, initial encounter Billable
T47.0X5D - Adverse effect of histamine H2-receptor blockers, subsequent encounter Billable
T47.0X5S - Adverse effect of histamine H2-receptor blockers, sequela Billable
T47.0X6S - Underdosing of histamine H2-receptor blockers, sequela Billable
T47.1X1S - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela Billable
T47.1X2S - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela Billable
T47.1X3S - Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela Billable
T47.1X4S - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela Billable
T47.1X5 - Adverse effect of other antacids and anti-gastric-secretion drugs Non-Billable
T47.1X5A - Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter Billable
T47.1X5D - Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter Billable
T47.1X5S - Adverse effect of other antacids and anti-gastric-secretion drugs, sequela Billable
T47.1X6S - Underdosing of other antacids and anti-gastric-secretion drugs, sequela Billable
T47.2X1S - Poisoning by stimulant laxatives, accidental (unintentional), sequela Billable
T47.2X2S - Poisoning by stimulant laxatives, intentional self-harm, sequela Billable
T47.2X3S - Poisoning by stimulant laxatives, assault, sequela Billable
T47.2X4S - Poisoning by stimulant laxatives, undetermined, sequela Billable
T47.2X5 - Adverse effect of stimulant laxatives Non-Billable
T47.2X5A - Adverse effect of stimulant laxatives, initial encounter Billable
T47.2X5D - Adverse effect of stimulant laxatives, subsequent encounter Billable
T47.2X5S - Adverse effect of stimulant laxatives, sequela Billable
T47.2X6S - Underdosing of stimulant laxatives, sequela Billable
T47.3X1S - Poisoning by saline and osmotic laxatives, accidental (unintentional), sequela Billable
T47.3X2S - Poisoning by saline and osmotic laxatives, intentional self-harm, sequela Billable
T47.3X3S - Poisoning by saline and osmotic laxatives, assault, sequela Billable
T47.3X4S - Poisoning by saline and osmotic laxatives, undetermined, sequela Billable
T47.3X5 - Adverse effect of saline and osmotic laxatives Non-Billable
T47.3X5A - Adverse effect of saline and osmotic laxatives, initial encounter Billable
T47.3X5D - Adverse effect of saline and osmotic laxatives, subsequent encounter Billable
T47.3X5S - Adverse effect of saline and osmotic laxatives, sequela Billable
T47.3X6S - Underdosing of saline and osmotic laxatives, sequela Billable
T47.4X1S - Poisoning by other laxatives, accidental (unintentional), sequela Billable
T47.4X2S - Poisoning by other laxatives, intentional self-harm, sequela Billable
T47.4X3S - Poisoning by other laxatives, assault, sequela Billable
T47.4X4S - Poisoning by other laxatives, undetermined, sequela Billable
T47.4X5 - Adverse effect of other laxatives Non-Billable
T47.4X5A - Adverse effect of other laxatives, initial encounter Billable
T47.4X5D - Adverse effect of other laxatives, subsequent encounter Billable
T47.4X5S - Adverse effect of other laxatives, sequela Billable
T47.4X6S - Underdosing of other laxatives, sequela Billable
T47.5X1S - Poisoning by digestants, accidental (unintentional), sequela Billable
T47.5X2S - Poisoning by digestants, intentional self-harm, sequela Billable
T47.5X3S - Poisoning by digestants, assault, sequela Billable
T47.5X4S - Poisoning by digestants, undetermined, sequela Billable
T47.5X5 - Adverse effect of digestants Non-Billable
T47.5X5A - Adverse effect of digestants, initial encounter Billable
T47.5X5D - Adverse effect of digestants, subsequent encounter Billable
T47.5X5S - Adverse effect of digestants, sequela Billable
T47.5X6S - Underdosing of digestants, sequela Billable
T47.6X1S - Poisoning by antidiarrheal drugs, accidental (unintentional), sequela Billable
T47.6X2S - Poisoning by antidiarrheal drugs, intentional self-harm, sequela Billable
T47.6X3S - Poisoning by antidiarrheal drugs, assault, sequela Billable
T47.6X4S - Poisoning by antidiarrheal drugs, undetermined, sequela Billable
T47.6X5 - Adverse effect of antidiarrheal drugs Non-Billable
T47.6X5A - Adverse effect of antidiarrheal drugs, initial encounter Billable
T47.6X5D - Adverse effect of antidiarrheal drugs, subsequent encounter Billable
T47.6X5S - Adverse effect of antidiarrheal drugs, sequela Billable
T47.6X6S - Underdosing of antidiarrheal drugs, sequela Billable
T47.7X1S - Poisoning by emetics, accidental (unintentional), sequela Billable
T47.7X2S - Poisoning by emetics, intentional self-harm, sequela Billable
T47.7X3S - Poisoning by emetics, assault, sequela Billable
T47.7X4S - Poisoning by emetics, undetermined, sequela Billable
T47.7X5 - Adverse effect of emetics Non-Billable
T47.7X5A - Adverse effect of emetics, initial encounter Billable
T47.7X5D - Adverse effect of emetics, subsequent encounter Billable
T47.7X5S - Adverse effect of emetics, sequela Billable
T47.7X6S - Underdosing of emetics, sequela Billable
T47.8X1S - Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela Billable
T47.8X2S - Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela Billable
T47.8X3S - Poisoning by other agents primarily affecting gastrointestinal system, assault, sequela Billable
T47.8X4S - Poisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela Billable
T47.8X5 - Adverse effect of other agents primarily affecting gastrointestinal system Non-Billable
T47.8X5A - Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter Billable
T47.8X5D - Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter Billable
T47.8X5S - Adverse effect of other agents primarily affecting gastrointestinal system, sequela Billable
T47.8X6S - Underdosing of other agents primarily affecting gastrointestinal system, sequela Billable
T47.91XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela Billable
T47.92XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela Billable
T47.93XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela Billable
T47.94XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela Billable
T47.95 - Adverse effect of unspecified agents primarily affecting the gastrointestinal system Non-Billable
T47.95XA - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter Billable
T47.95XD - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter Billable
T47.95XS - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela Billable
T47.96XS - Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela Billable
T50.0X1S - Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela Billable
T50.0X2S - Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela Billable
T50.0X3S - Poisoning by mineralocorticoids and their antagonists, assault, sequela Billable
T50.0X4S - Poisoning by mineralocorticoids and their antagonists, undetermined, sequela Billable
T50.0X5 - Adverse effect of mineralocorticoids and their antagonists Non-Billable
T50.0X5A - Adverse effect of mineralocorticoids and their antagonists, initial encounter Billable
T50.0X5D - Adverse effect of mineralocorticoids and their antagonists, subsequent encounter Billable
T50.0X5S - Adverse effect of mineralocorticoids and their antagonists, sequela Billable
T50.0X6S - Underdosing of mineralocorticoids and their antagonists, sequela Billable
T50.1X1S - Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), sequela Billable
T50.1X2S - Poisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela Billable
T50.1X3S - Poisoning by loop [high-ceiling] diuretics, assault, sequela Billable
T50.1X4S - Poisoning by loop [high-ceiling] diuretics, undetermined, sequela Billable
T50.1X5 - Adverse effect of loop [high-ceiling] diuretics Non-Billable
T50.1X5A - Adverse effect of loop [high-ceiling] diuretics, initial encounter Billable
T50.1X5D - Adverse effect of loop [high-ceiling] diuretics, subsequent encounter Billable
T50.1X5S - Adverse effect of loop [high-ceiling] diuretics, sequela Billable
T50.1X6S - Underdosing of loop [high-ceiling] diuretics, sequela Billable
T50.2X1S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), sequela Billable
T50.2X2S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela Billable
T50.2X3S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela Billable
T50.2X4S - Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, sequela Billable
T50.2X5 - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics Non-Billable
T50.2X5A - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter Billable
T50.2X5D - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter Billable
T50.2X5S - Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela Billable
T50.2X6S - Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela Billable
T50.3X1S - Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), sequela Billable
T50.3X2S - Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela Billable
T50.3X3S - Poisoning by electrolytic, caloric and water-balance agents, assault, sequela Billable
T50.3X4S - Poisoning by electrolytic, caloric and water-balance agents, undetermined, sequela Billable
T50.3X5 - Adverse effect of electrolytic, caloric and water-balance agents Non-Billable
T50.3X5A - Adverse effect of electrolytic, caloric and water-balance agents, initial encounter Billable
T50.3X5D - Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter Billable
T50.3X5S - Adverse effect of electrolytic, caloric and water-balance agents, sequela Billable
T50.3X6S - Underdosing of electrolytic, caloric and water-balance agents, sequela Billable
T50.4X1S - Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), sequela Billable
T50.4X2S - Poisoning by drugs affecting uric acid metabolism, intentional self-harm, sequela Billable
T50.4X3S - Poisoning by drugs affecting uric acid metabolism, assault, sequela Billable
T50.4X4S - Poisoning by drugs affecting uric acid metabolism, undetermined, sequela Billable
T50.4X5 - Adverse effect of drugs affecting uric acid metabolism Non-Billable
T50.4X5A - Adverse effect of drugs affecting uric acid metabolism, initial encounter Billable
T50.4X5D - Adverse effect of drugs affecting uric acid metabolism, subsequent encounter Billable
T50.4X5S - Adverse effect of drugs affecting uric acid metabolism, sequela Billable
T50.4X6S - Underdosing of drugs affecting uric acid metabolism, sequela Billable
T50.5X1S - Poisoning by appetite depressants, accidental (unintentional), sequela Billable
T50.5X2S - Poisoning by appetite depressants, intentional self-harm, sequela Billable
T50.5X3S - Poisoning by appetite depressants, assault, sequela Billable
T50.5X4S - Poisoning by appetite depressants, undetermined, sequela Billable
T50.5X5 - Adverse effect of appetite depressants Non-Billable
T50.5X5A - Adverse effect of appetite depressants, initial encounter Billable
T50.5X5D - Adverse effect of appetite depressants, subsequent encounter Billable
T50.5X5S - Adverse effect of appetite depressants, sequela Billable
T50.5X6S - Underdosing of appetite depressants, sequela Billable
T50.6X1S - Poisoning by antidotes and chelating agents, accidental (unintentional), sequela Billable
T50.6X2S - Poisoning by antidotes and chelating agents, intentional self-harm, sequela Billable
T50.6X3S - Poisoning by antidotes and chelating agents, assault, sequela Billable
T50.6X4S - Poisoning by antidotes and chelating agents, undetermined, sequela Billable
T50.6X5 - Adverse effect of antidotes and chelating agents Non-Billable
T50.6X5A - Adverse effect of antidotes and chelating agents, initial encounter Billable
T50.6X5D - Adverse effect of antidotes and chelating agents, subsequent encounter Billable
T50.6X5S - Adverse effect of antidotes and chelating agents, sequela Billable
T50.6X6S - Underdosing of antidotes and chelating agents, sequela Billable
T50.7X1S - Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), sequela Billable
T50.7X2S - Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, sequela Billable
T50.7X3S - Poisoning by analeptics and opioid receptor antagonists, assault, sequela Billable
T50.7X4S - Poisoning by analeptics and opioid receptor antagonists, undetermined, sequela Billable
T50.7X5 - Adverse effect of analeptics and opioid receptor antagonists Non-Billable
T50.7X5A - Adverse effect of analeptics and opioid receptor antagonists, initial encounter Billable
T50.7X5D - Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter Billable
T50.7X5S - Adverse effect of analeptics and opioid receptor antagonists, sequela Billable
T50.7X6S - Underdosing of analeptics and opioid receptor antagonists, sequela Billable
T50.8X1S - Poisoning by diagnostic agents, accidental (unintentional), sequela Billable
T50.8X2S - Poisoning by diagnostic agents, intentional self-harm, sequela Billable
T50.8X3S - Poisoning by diagnostic agents, assault, sequela Billable
T50.8X4S - Poisoning by diagnostic agents, undetermined, sequela Billable
T50.8X5 - Adverse effect of diagnostic agents Non-Billable
T50.8X5A - Adverse effect of diagnostic agents, initial encounter Billable
T50.8X5D - Adverse effect of diagnostic agents, subsequent encounter Billable
T50.8X5S - Adverse effect of diagnostic agents, sequela Billable
T50.8X6S - Underdosing of diagnostic agents, sequela Billable
T50.901S - Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela Billable
T50.902S - Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, sequela Billable
T50.903S - Poisoning by unspecified drugs, medicaments and biological substances, assault, sequela Billable
T50.904S - Poisoning by unspecified drugs, medicaments and biological substances, undetermined, sequela Billable
T50.905 - Adverse effect of unspecified drugs, medicaments and biological substances Non-Billable
T50.905A - Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter Billable
T50.905D - Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter Billable
T50.905S - Adverse effect of unspecified drugs, medicaments and biological substances, sequela Billable
T50.906S - Underdosing of unspecified drugs, medicaments and biological substances, sequela Billable
T50.911S - Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela Billable
T50.912S - Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, sequela Billable
T50.913S - Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, sequela Billable
T50.914S - Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, sequela Billable
T50.915 - Adverse effect of multiple unspecified drugs, medicaments and biological substances Non-Billable
T50.915A - Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter Billable
T50.915D - Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter Billable
T50.915S - Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela Billable
T50.916S - Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela Billable
T50.991S - Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), sequela Billable
T50.992S - Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela Billable
T50.993S - Poisoning by other drugs, medicaments and biological substances, assault, sequela Billable
T50.994S - Poisoning by other drugs, medicaments and biological substances, undetermined, sequela Billable
T50.995 - Adverse effect of other drugs, medicaments and biological substances Non-Billable
T45.7X1S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela Billable
T45.7X2S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela Billable
T45.7X3S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela Billable
T45.7X4S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela Billable
T45.7X5 - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants Non-Billable
T45.7X5A - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter Billable
T45.7X5D - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter Billable
T45.7X5S - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela Billable
T45.7X6S - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela Billable
T45.8X1S - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela Billable
T45.8X2S - Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela Billable
T45.8X3S - Poisoning by other primarily systemic and hematological agents, assault, sequela Billable
T45.8X4S - Poisoning by other primarily systemic and hematological agents, undetermined, sequela Billable
T45.8X5 - Adverse effect of other primarily systemic and hematological agents Non-Billable
T45.8X5A - Adverse effect of other primarily systemic and hematological agents, initial encounter Billable
T45.8X5D - Adverse effect of other primarily systemic and hematological agents, subsequent encounter Billable
T45.8X5S - Adverse effect of other primarily systemic and hematological agents, sequela Billable
T45.8X6S - Underdosing of other primarily systemic and hematological agents, sequela Billable
T45.91XS - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela Billable
T45.92XS - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela Billable
T45.93XS - Poisoning by unspecified primarily systemic and hematological agent, assault, sequela Billable
T45.94XS - Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela Billable
T45.95 - Adverse effect of unspecified primarily systemic and hematological agent Non-Billable
T45.95XA - Adverse effect of unspecified primarily systemic and hematological agent, initial encounter Billable
T45.95XD - Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter Billable
T45.95XS - Adverse effect of unspecified primarily systemic and hematological agent, sequela Billable
T45.96XS - Underdosing of unspecified primarily systemic and hematological agent, sequela Billable
T45.AX5 - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs Non-Billable
T49.0X1S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), sequela Billable
T49.0X2S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, sequela Billable
T49.0X3S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, sequela Billable
T49.0X4S - Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, sequela Billable
T49.0X5 - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs Non-Billable
T49.0X5A - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter Billable
T49.0X5D - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter Billable
T49.0X5S - Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela Billable
T49.0X6S - Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela Billable
T49.1X1S - Poisoning by antipruritics, accidental (unintentional), sequela Billable
T49.1X2S - Poisoning by antipruritics, intentional self-harm, sequela Billable
T49.1X3S - Poisoning by antipruritics, assault, sequela Billable
T49.1X4S - Poisoning by antipruritics, undetermined, sequela Billable
T49.1X5 - Adverse effect of antipruritics Non-Billable
T49.1X5A - Adverse effect of antipruritics, initial encounter Billable
T49.1X5D - Adverse effect of antipruritics, subsequent encounter Billable
T49.1X5S - Adverse effect of antipruritics, sequela Billable
T49.1X6S - Underdosing of antipruritics, sequela Billable
T49.2X1S - Poisoning by local astringents and local detergents, accidental (unintentional), sequela Billable
T49.2X2S - Poisoning by local astringents and local detergents, intentional self-harm, sequela Billable
T49.2X3S - Poisoning by local astringents and local detergents, assault, sequela Billable
T49.2X4S - Poisoning by local astringents and local detergents, undetermined, sequela Billable
T49.2X5 - Adverse effect of local astringents and local detergents Non-Billable
T49.2X5A - Adverse effect of local astringents and local detergents, initial encounter Billable
T49.2X5D - Adverse effect of local astringents and local detergents, subsequent encounter Billable
T49.2X5S - Adverse effect of local astringents and local detergents, sequela Billable
T49.2X6S - Underdosing of local astringents and local detergents, sequela Billable
T49.3X1S - Poisoning by emollients, demulcents and protectants, accidental (unintentional), sequela Billable
T49.3X2S - Poisoning by emollients, demulcents and protectants, intentional self-harm, sequela Billable
T49.3X3S - Poisoning by emollients, demulcents and protectants, assault, sequela Billable
T49.3X4S - Poisoning by emollients, demulcents and protectants, undetermined, sequela Billable
T49.3X5 - Adverse effect of emollients, demulcents and protectants Non-Billable
T49.3X5A - Adverse effect of emollients, demulcents and protectants, initial encounter Billable
T49.3X5D - Adverse effect of emollients, demulcents and protectants, subsequent encounter Billable
T49.3X5S - Adverse effect of emollients, demulcents and protectants, sequela Billable
T49.3X6S - Underdosing of emollients, demulcents and protectants, sequela Billable
T49.4X1S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), sequela Billable
T49.4X2S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, sequela Billable
T49.4X3S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, sequela Billable
T49.4X4S - Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, sequela Billable
T49.4X5 - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations Non-Billable
T49.4X5A - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter Billable
T49.4X5D - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter Billable
T49.4X5S - Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela Billable
T49.4X6S - Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela Billable
T49.5X1S - Poisoning by ophthalmological drugs and preparations, accidental (unintentional), sequela Billable
T49.5X2S - Poisoning by ophthalmological drugs and preparations, intentional self-harm, sequela Billable
T49.5X3S - Poisoning by ophthalmological drugs and preparations, assault, sequela Billable
T49.5X4S - Poisoning by ophthalmological drugs and preparations, undetermined, sequela Billable
T49.5X5 - Adverse effect of ophthalmological drugs and preparations Non-Billable
T49.5X5A - Adverse effect of ophthalmological drugs and preparations, initial encounter Billable
T49.5X5D - Adverse effect of ophthalmological drugs and preparations, subsequent encounter Billable
T49.5X5S - Adverse effect of ophthalmological drugs and preparations, sequela Billable
T49.5X6S - Underdosing of ophthalmological drugs and preparations, sequela Billable
T49.6X1S - Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), sequela Billable
T49.6X2S - Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, sequela Billable
T49.6X3S - Poisoning by otorhinolaryngological drugs and preparations, assault, sequela Billable
T49.6X4S - Poisoning by otorhinolaryngological drugs and preparations, undetermined, sequela Billable
T49.6X5 - Adverse effect of otorhinolaryngological drugs and preparations Non-Billable
T49.6X5A - Adverse effect of otorhinolaryngological drugs and preparations, initial encounter Billable
T49.6X5D - Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter Billable
T49.6X5S - Adverse effect of otorhinolaryngological drugs and preparations, sequela Billable
T49.6X6S - Underdosing of otorhinolaryngological drugs and preparations, sequela Billable
T49.7X1S - Poisoning by dental drugs, topically applied, accidental (unintentional), sequela Billable
T49.7X2S - Poisoning by dental drugs, topically applied, intentional self-harm, sequela Billable
T49.7X3S - Poisoning by dental drugs, topically applied, assault, sequela Billable
T49.7X4S - Poisoning by dental drugs, topically applied, undetermined, sequela Billable
T49.7X5 - Adverse effect of dental drugs, topically applied Non-Billable
T49.7X5A - Adverse effect of dental drugs, topically applied, initial encounter Billable
T49.7X5D - Adverse effect of dental drugs, topically applied, subsequent encounter Billable
T49.7X5S - Adverse effect of dental drugs, topically applied, sequela Billable
T49.7X6S - Underdosing of dental drugs, topically applied, sequela Billable
T49.8X1S - Poisoning by other topical agents, accidental (unintentional), sequela Billable
T49.8X2S - Poisoning by other topical agents, intentional self-harm, sequela Billable
T49.8X3S - Poisoning by other topical agents, assault, sequela Billable
T49.8X4S - Poisoning by other topical agents, undetermined, sequela Billable
T49.8X5 - Adverse effect of other topical agents Non-Billable
T49.8X5A - Adverse effect of other topical agents, initial encounter Billable
T49.8X5D - Adverse effect of other topical agents, subsequent encounter Billable
T49.8X5S - Adverse effect of other topical agents, sequela Billable
T49.8X6S - Underdosing of other topical agents, sequela Billable
T49.91XS - Poisoning by unspecified topical agent, accidental (unintentional), sequela Billable
T49.92XS - Poisoning by unspecified topical agent, intentional self-harm, sequela Billable
T49.93XS - Poisoning by unspecified topical agent, assault, sequela Billable
T49.94XS - Poisoning by unspecified topical agent, undetermined, sequela Billable
T49.95 - Adverse effect of unspecified topical agent Non-Billable
T49.95XA - Adverse effect of unspecified topical agent, initial encounter Billable
T49.95XD - Adverse effect of unspecified topical agent, subsequent encounter Billable
T49.95XS - Adverse effect of unspecified topical agent, sequela Billable
T49.96XS - Underdosing of unspecified topical agent, sequela Billable